Batten's disease comprises the late infantile and juvenile types of neuronal ceroid-lipofuscinosis(LINCL and JNCL). The underlying pathophysiology of this group of diseases remains poorly understood. The determination of the responsible genetic defects at a molecular level will 1) explain heterogeneity between and within clinical subtypes; 2) revolutionize diagnostic methods by providing subtype-specific carrier and prenatal detection; 3) provide valuable insight into mechanisms of rapid neuronal cell death and the role of defective gene products in the developing nervous system. Detailed clinical and linkage studies by the investigator have established LINCL and JNCL as two distinct entities. We have shown JNCL to be linked to the haptoglobin locus. LINCL has been and will remain a poor substrate for linkage studies as the number of multiaffected families are limited due to the early demise of these patients. Fortunately, recent biochemical evidence on accumulation in the lysosome of subunit-9 of ATP synthase and dolichyl-pyrophosphate oligosaccharides that have already undergone processing implicates at least one of four genes in the pathogenesis of Batten's disease: These are the two genes coding for the precursors of subunit-9 of mitochondrial ATP synthase and the genes for microsomal glucosidase and glucosidase II. This application proposes to 1) clone the normal cDNAs for subunit-9 and study regulation of subunit-9 expression in humans by """"""""anchored PCR"""""""" and Northern blot analysis; 2) determine the type and level of expression of subunit-9 in LINCL using the normal cDNAs as probes, detect mutations in the cDNAs for subunit-9 in LINCL by cloning and sequencing., and to confirm the occurrence of these mutations in genomic DNA from LINCL patients in single or double dose by allele-specific hybridization; 3) determine activity levels of microsomal glucosidase I and II in LINCL and JNCL by developing assay methods in human fibroblasts and lymphoblasts using colorimetric and radioactive substrates; 4) determine the effects of microsomal glucosidase I and II activity on subunit-9 accumulation in normal and Batten cell lines by Western Blot and ELISA using an affinity purified subunit-9-specific antibody. It is hoped that these studies will provide important and novel information on the etiology and pathogenesis of Batten's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS030170-04
Application #
2268239
Study Section
Special Emphasis Panel (ZRG1-NLS-1 (01))
Project Start
1992-09-07
Project End
1996-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Duke University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Gao, Hanlin; Boustany, Rose-Mary N; Espinola, Janice A et al. (2002) Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet 70:324-35
Dhar, Sumeer; Bitting, Rhonda L; Rylova, Svetlana N et al. (2002) Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons. Ann Neurol 51:448-66
Rylova, Svetlana N; Amalfitano, Andrea; Persaud-Sawin, Dixie-Ann et al. (2002) The CLN3 gene is a novel molecular target for cancer drug discovery. Cancer Res 62:801-8
Persaud-Sawin, Dixie-Ann N W; VanDongen, Antonius; Boustany, Rose-Mary N (2002) Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis. Hum Mol Genet 11:2129-42
Pane, M A; Puranam, K L; Boustany, R M (1999) Expression of cln3 in human NT2 neuronal precursor cells and neonatal rat brain. Pediatr Res 46:367-74
Guo, W X; Mao, C; Obeid, L M et al. (1999) A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae: a model to study Batten disease. Cell Mol Neurobiol 19:671-80
Puranam, K L; Guo, W X; Qian, W H et al. (1999) CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol Genet Metab 66:294-308
Puranam, K; Qian, W H; Nikbakht, K et al. (1997) Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics 28:37-41
Bennett, M J; Boriack, R L; Boustany, R M (1997) Polyunsaturated fatty acids reverse the lysosomal storage and accumulation of subunit 9 of mitochondrial F1F0-ATP synthase in cultured lymphoblasts from patients with Batten disease. J Inherit Metab Dis 20:457-60
Lane, S C; Jolly, R D; Schmechel, D E et al. (1996) Apoptosis as the mechanism of neurodegeneration in Batten's disease. J Neurochem 67:677-83

Showing the most recent 10 out of 11 publications